Acorda Therapeutics Inc (NASDAQ:ACOR)

Delayed Data
As of Jun 15
 -0.35 / -1.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 23.00, with a high estimate of 31.00 and a low estimate of 17.00. The median estimate represents a -26.16% decrease from the last price of 31.15.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 387.76%
Growthannually -129.06%


Growthquarterly 27.80%
Growthannually -41.08%
Key to the earnings and sales forecast charts.